UY37824A - Forma cristalina de ácido (2s)-2-[[(z)-[1-(2-amino-4-tiazolil)-2-[[(3s)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3r)-3-piperidinilamino]metil]fenoxi]-propanoico - Google Patents

Forma cristalina de ácido (2s)-2-[[(z)-[1-(2-amino-4-tiazolil)-2-[[(3s)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3r)-3-piperidinilamino]metil]fenoxi]-propanoico

Info

Publication number
UY37824A
UY37824A UY0001037824A UY37824A UY37824A UY 37824 A UY37824 A UY 37824A UY 0001037824 A UY0001037824 A UY 0001037824A UY 37824 A UY37824 A UY 37824A UY 37824 A UY37824 A UY 37824A
Authority
UY
Uruguay
Prior art keywords
amino
imino
phenoxy
oxo
methyl
Prior art date
Application number
UY0001037824A
Other languages
English (en)
Inventor
Susanne Bonsmann
Wilfried Schwab Dr
Burkhard Klenke Dr
Original Assignee
Aicuris Anti Infective Cures Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Anti Infective Cures Gmbh filed Critical Aicuris Anti Infective Cures Gmbh
Publication of UY37824A publication Critical patent/UY37824A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a la primera forma cristalina del ácido (2S)-2-[[(Z)-[1-(2-amino-4-tiazolil)-2-[[(3S)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3R)-3- piperidinilamino]metil]fenoxi]-propanoico, es decir, el compuesto de fórmula (I).
UY0001037824A 2017-07-28 2018-07-27 Forma cristalina de ácido (2s)-2-[[(z)-[1-(2-amino-4-tiazolil)-2-[[(3s)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3r)-3-piperidinilamino]metil]fenoxi]-propanoico UY37824A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17183862 2017-07-28

Publications (1)

Publication Number Publication Date
UY37824A true UY37824A (es) 2019-02-28

Family

ID=59485296

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037824A UY37824A (es) 2017-07-28 2018-07-27 Forma cristalina de ácido (2s)-2-[[(z)-[1-(2-amino-4-tiazolil)-2-[[(3s)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3r)-3-piperidinilamino]metil]fenoxi]-propanoico

Country Status (4)

Country Link
AR (1) AR112464A1 (es)
TW (1) TW201920163A (es)
UY (1) UY37824A (es)
WO (1) WO2019020810A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111592536B (zh) * 2020-06-04 2023-11-03 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺化合物及其制备方法和应用
CN115210231B (zh) * 2020-07-16 2024-10-08 宁夏农林科学院 单环内酰胺类化合物、其制备方法及其作为抗菌药的用途
US20230150996A1 (en) * 2020-08-06 2023-05-18 Ningxia Academy Of Agriculture And Forestry Sciences B-lactam compounds, their preparation and use as antibacterial agents
IL312841A (en) 2021-11-18 2024-07-01 Merck Sharp & Dohme Llc CHROMANE AMIDINE MONOBACTAM ANTIBIOTICS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Also Published As

Publication number Publication date
AR112464A1 (es) 2019-10-30
TW201920163A (zh) 2019-06-01
WO2019020810A1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
UY37824A (es) Forma cristalina de ácido (2s)-2-[[(z)-[1-(2-amino-4-tiazolil)-2-[[(3s)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3r)-3-piperidinilamino]metil]fenoxi]-propanoico
CL2017000705A1 (es) Nuevos compuestos
AR116394A2 (es) Mesilato de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato
CY1118435T1 (el) Παραγωγο μορφολινο νουκλεϊνικου οξεος
EA201592305A1 (ru) Способ получения и кристаллические формы ингибитора mdm2
PE20170664A1 (es) Agonistas del receptor de apelina(apj) y usos de los mismos
AR098929A1 (es) Formas sólidas cristalinas del compuesto 2-((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforilamino)propanoato
PE20142403A1 (es) Compuestos inhibidores de beta-lactamasas
PE20140849A1 (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
ES2723277T3 (es) Una forma sólida de clorhidrato de (S)-3-(4-((4-morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidina-2,6-diona
BR112015000160A2 (pt) fabricação de ácido 2-(5-bromo-4-(4-ciclopropil hidronaftalen-1-il)-4h-1,2,4-triazol-3-il-tio) acético
AR078944A1 (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
MY172534A (en) Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
CO6210692A2 (es) Derivados de hidantoina usados como inhibidores de mmp
PE20090243A1 (es) Compuestos de imidazol sustituido como inhibidores de renina
WO2014188453A3 (en) Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CL2021000454A1 (es) Método para preparar 2-[(3r)-3--metilmofolin--4-il]-4-(1-metil-1h-pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina
PE20061421A1 (es) Compuestos de n-formil-hidroxilamina como inhibidores de peptidil-desformilasa
CY1122506T1 (el) Κρυσταλλικη μορφη της ενωσης (s)-3-{4-[5-(2-κυκλοπεντυλ-6- μεθοξυ- πυριδιν-4- υλ)-[1,2,4]οξαδιαζολ-3- υλ]-2- αιθυλ-6-μεθυλ- φαινοξυ}- προπανο-1,2- διολη
ECSP11011081A (es) 3-aminociclopentancarboxamidas
CO6260137A2 (es) Compuesto de epoxi y metodo para fabricar el mismo
CO6460700A2 (es) Compuesto de pirazol
CO6700844A2 (es) Nuevas formas cristalinas del ácido (e)-3-(2-(1-((2-(5-bromo-pirimidin-2-il)-3- ciclopentil-1 metil-1h indol-6-carbonil)-amino)-ciclobutil-3-metil-3h-bacimidazol-5-)-acrílicos como inhibidores de vhc
MX365948B (es) Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida.
NI200900154A (es) Nuevos procedimiento de obtención de la forma cristalina v de la agomelatina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20231110